50 years after it was first proposed, gene therapy - the modification of DNA to treat disease - has gone from science fiction to clinical reality. However, as prices for gene therapies are released, widespread sticker-shock is raising questions about affordability and fair pricing.
'Bionic life' utilizes non-biological supermaterials to give organisms emergent properties outside the scope of evolution. Analogous to space suits worn by astronauts, such materials can protect an organism from harsh and toxic environments, and allow them to live off normally indigestible molecules. This technology has the potential to revolutionize areas such as the pharmaceutical industry, toxic waste remediation and space travel.
Show your workings! Why transparency in the evidence used in policymaking matters, and why the public care to know. With a clear chain of reasoning and meaningful transparency, trust can be built between the government and the public on matters that affect us all.
Can climate information serve as a possible adaptation strategy to changing climate conditions?
Tackling global challenges, one issue at a time. From energy and the environment to economics, development and global health, our expert contributors look at all angles. ANGLE focuses on the intersection of science, policy and politics in an evolving and complex world.
Brought to you from the team at Imperial College's A Global Village.
Science is experiencing a crisis which revolves around scholarly publishing. The open access model of “pay to publish”, in which authors pay a charge to cover production and subscription costs, is increasingly shaking the traditional subscription model in which universities pay for access. Can we move away from today’s profit-driven publishing model and towards an open, shared and collaborative scientific community?
